Factors determining patient choice of device for GH therapy.
about
Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patientsMaintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing jet-delivery and needle-based devices.Acceptability of the reusable SurePal™ self-injection device for Omnitrope(®) among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study.Easypod: a new electronic injection device for growth hormone.Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.Stories of experiences of care for growth hormone deficiency: the CRESCERE project.Human growth hormone treatment: synthesis of literature on product delivery systems and administration practices.Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences.Growth hormone delivery devices: current features and potential for enhanced treatment adherence.Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use.Patients' perceptions on the usability of the SurePal™ self-injection device for Omnitrope®: a questionnaire-based observational study conducted in paediatric patients in France.Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device.Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay.
P2860
Q30494203-5161C1BF-BB21-4949-B307-F2A596104C5BQ31132672-97AE5B22-74B6-4B5A-A047-2B11572674EFQ34230388-F0A0A75D-51ED-43D3-85B1-5EC01EF9529AQ36082213-55811047-CF04-4E37-B9AB-0208DDA36ADFQ37152832-D5915615-F358-4993-ADE1-46CB6874283EQ37165184-01BDCA7A-25D1-4FCC-AA9E-ED0A7929A3F2Q37474315-AAFF18B5-5258-491F-95FD-5D668D0E78D5Q37835881-C31A7890-305D-4305-8632-4A10B0E68417Q38096485-02ADA7CD-450D-4D91-A81A-1ACC96C4D655Q38705140-AE7BFDDE-EB2B-44B9-9B84-C30FBC0D8194Q38841536-681C4110-1773-447D-8186-A9690B6F62D1Q38975711-D940C5AB-73F5-4F8E-A857-C1FBBEC2C9A1Q40549992-58D03299-4901-4415-80E5-F210D31338B6Q42375632-5CD91979-7F7C-4FDB-8F18-12CF643205B0Q42972554-D1213A85-E285-4769-A682-EF870561962DQ45285454-16468E18-9DE2-4039-9FF5-8F996DE84578Q52624558-7E1FCB0E-8243-4418-9D58-B03F705B3F84Q53659540-B5A2564B-D8ED-40DA-9BDA-86D2E59A3C9B
P2860
Factors determining patient choice of device for GH therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Factors determining patient choice of device for GH therapy.
@en
Factors determining patient choice of device for GH therapy.
@nl
type
label
Factors determining patient choice of device for GH therapy.
@en
Factors determining patient choice of device for GH therapy.
@nl
prefLabel
Factors determining patient choice of device for GH therapy.
@en
Factors determining patient choice of device for GH therapy.
@nl
P2093
P356
P1433
P1476
Factors determining patient choice of device for GH therapy
@en
P2093
Ehtisham S
Wickramasuriya BP
P2860
P356
10.1159/000090375
P577
2005-12-16T00:00:00Z